Evidence map›Paper›PMID 22389497›Full record

ReviewThe Journal of biological chemistry2012

Structure-function relationships in [FeFe]-hydrogenase active site maturation.

Yvain Nicolet, Juan C Fontecilla-Camps

Open access · hybridAbstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. CO and CN- syntheses by [FeFe]-hydrogenase maturase HydG are catalytically differentiated events.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  11. Cysteine as a ligand platform in the biosynthesis of the FeFe hydrogenase H cluster.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Yvain NicoletMetalloproteins Unit, Institut de Biologie Structurale Jean-Pierre Ebel, Commissariat à l'Energie Atomique, CNRS, Université Joseph Fourier, 38027 Grenoble Cedex 1, France.
Juan C Fontecilla-Camps
Centre National de la Recherche Scientifique · FRUniversité Joseph Fourier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the discovery that, despite the active site complexity, only three gene products suffice to obtain active recombinant [FeFe]-hydrogenase, significant light has been shed on this process. Both the source of the CO and CN(-) ligands to iron and the assembly site of the catalytic subcluster are known, and an apo structure of HydF has been published recently. However, the nature of the substrate(s) for the synthesis of the bridging dithiolate ligand to the subcluster remains to be established. From both spectroscopy and model chemistry, it is predicted that an amine function in this ligand plays a central role in catalysis, acting as a base in the heterolytic cleavage of hydrogen.

Indexed as

AlgorithmsBiochemistryCatalysisCatalytic DomainChlamydomonasEscherichia coli ProteinsGiardiaHydrogenHydrogenaseIron-Sulfur ProteinsLigandsModels, ChemicalModels, MolecularMolecular ConformationRecombinant ProteinsSpectrophotometryEscherichia coli ProteinsHydrogenHydrogenaseiron hydrogenaseIron-Sulfur ProteinsLigandsRecombinant ProteinsTrans-ActivatorszraR protein, E coli

Identifiers

PMID22389497
PMCPMC3340144
OpenAlexW2009080760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.